CMF
AVNS

Counterpoint Mutual Funds’s Avanos Medical AVNS Stock Holding History

Counterpoint Mutual Funds’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,083
Closed -$540K – 313
2025
Q4 		$540K Buy
48,083
+18,482
+62% +$211K 0.04% 80
2025
Q3 		$342K Buy
29,601
+6,052
+26% +$70.9K 0.03% 274
2025
Q2 		$288K Buy
+23,549
New +$296K 0.03% 293
2023
Q2 		– Sell
-3,729
Closed -$111K – 306
2023
Q1 		$111K Sell
3,729
-1,177
-24% -$34.2K 0.1% 146
2022
Q4 		$133K Buy
+4,906
New +$120K 0.14% 170

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Counterpoint Mutual Funds's AVNS Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 48,083 shares — an estimated $540K sold.

Counterpoint Mutual Funds first reported a position in AVNS in Q4 2022 and held it in 5 quarters. The position peaked at $540K in Q4 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Counterpoint Mutual Funds reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 48,083 Avanos Medical shares in Q1 2026, an estimated $540K.
  • Counterpoint Mutual Funds first reported a position in Avanos Medical in Q4 2022 and held it in 5 quarters.
  • Counterpoint Mutual Funds's Avanos Medical position peaked at $540K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.